Cancer research
Cancer is a leading cause of death, accounting for nearly one in six deaths worldwide. Many cancers can be cured, especially if detected early and treated effectively. Nevertheless, an unmet need for the development of treatments for aggressive and often metastatic tumors remains. Preclinical and clinical research in the areas of cancer screening and detection, as well as development of new therapies are at the core of this challenge. This development is cemented by an understanding of basic cancer biology and tumor immunology and tumor profiling studies that link bench and bedside to allow for an improved understanding of therapy response and resistance. In this collection, we highlight the breadth of cancer research in these areas at the Nature Portfolio.
-
Produced with support from:
This Collection is editorially independent, produced with financial support from a third party. About this content.
Nature Portfolio is pleased to acknowledge financial support from Pfizer in producing this Collection. The sponsor retains sole responsibility for the following message.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
